Antigen presentation of extracellular pathogens by antigen presenting cells requires endocytosis of the antigen, followed by the degradation in the acidic environment of the formed phagolysosome. Should the phagolysosome become unable to lower its pH, what is the most likely consequence?

Deficient presentation of pathogens to CD4 T-cells

Deficient presentation of pathogens to CD8 T-cells

A 50-year-old man presents to the office with the complaint of pain in his left great toe. The pain started 2 days ago and has been progressively getting worse to the point that it is difficult to walk even a few steps. He adds that his left big toe is swollen and hot to the touch. He has never had similar symptoms in the past. He normally drinks 2–3 cans of beer every night but recently binge drank 3 nights ago. Physical examination is notable for an overweight gentleman (BMI of 35) in moderate pain, with an erythematous, swollen, and exquisitely tender left great toe. Laboratory results reveal a uric acid level of 9 mg/dL. A complete blood count shows: Hemoglobin % 12 gm/dL Hematocrit 45% Mean corpuscular volume (MCV) 90 fL Platelets 160,000/mm3 Leukocytes 8,000/mm3 Segmented neutrophils 65% Lymphocytes 25% Eosinophils 3% Monocytes 7% RBCs 5.6 million/mm3 Synovial fluid analysis shows: Cell count 55,000 cells/mm3 (80% neutrophils) Crystals negatively birefringent crystals present Culture pending Gram stain no organisms seen Which of the following is the mechanism of action of the drug that will most likely be used in the long-term management of this patient?

Activates adenosine monophosphate (AMP) deaminase

Inhibits renal clearance of uric acid

Activates inosine monophosphate (IMP) dehydrogenase

Increases renal clearance of uric acid

A 10-day-old infant with MSUD is admitted with lethargy, poor feeding, and plasma leucine of 2000 μmol/L (normal <200). Despite BCAA-free formula, the infant's condition worsens with encephalopathy. The neonatology team proposes hemodialysis, while the genetics team suggests continuing medical management with high-calorie IV fluids. The family is concerned about invasive procedures. Evaluate the optimal management strategy.

Immediate hemodialysis to rapidly lower leucine levels

High-dose thiamine trial before considering dialysis

Continue medical management and reassess in 24 hours

Exchange transfusion with albumin solutions

Start peritoneal dialysis as less invasive alternative

A research study compares three siblings with homocystinuria: one responds to pyridoxine therapy, one responds to betaine, and one requires both treatments plus dietary restriction. All have elevated homocysteine but different methionine levels. Analyze which underlying molecular mechanism best explains the variable treatment responses among these siblings.

Different mutations in the same CBS gene causing varying residual enzyme activity

Variable dietary methionine intake affecting phenotype expression

Different epigenetic modifications of the CBS gene

Varying levels of cystathionine β-synthase inhibitors

Mutations in three different genes affecting homocysteine metabolism

A 4-year-old boy presents with dark urine that turns black upon standing. His parents report that his diapers developed dark stains since infancy. Physical examination is otherwise normal. Urine analysis shows elevated homogentisic acid. What metabolic consequence is this patient at risk for developing in adulthood?

Ochronotic arthropathy affecting spine and large joints

Progressive intellectual disability and seizures

Cardiomyopathy with heart failure

Cirrhosis with portal hypertension

Chronic kidney disease from renal stone formation

A newborn screening program detects elevated leucine levels in a 3-day-old infant who appears clinically normal. Confirmatory testing shows elevated branched-chain amino acids. The parents ask about immediate treatment versus watchful waiting given the infant's current stable condition. Synthesize the most appropriate counseling and management approach.

Immediate initiation of BCAA-restricted formula regardless of symptoms

Genetic counseling with delayed treatment pending mutation analysis

Reassure parents and recheck in one week since infant is asymptomatic

Start treatment only if ketoacidosis develops

Wait for development of sweet-smelling urine before treatment

A 14-year-old boy with a history of intellectual disability presents to the emergency department with acute hemiparesis and altered mental status. He has ectopia lentis and marfanoid habitus. MRI shows acute ischemic stroke. Laboratory studies reveal elevated plasma homocysteine (180 μmol/L; normal <15) and methionine (65 μmol/L; normal 10-40). Genetic testing shows compound heterozygous mutations in CBS gene. Evaluate the most appropriate long-term management strategy.

High-dose pyridoxine, betaine, folate, and vitamin B12 supplementation

Cysteine supplementation with periodic plasmapheresis

Lifelong anticoagulation with warfarin alone

Immediate liver transplantation for enzyme replacement

Low-methionine diet with antiplatelet therapy only

A 25-year-old woman with a history of childhood PKU, now on a relaxed diet, is planning pregnancy. Her current phenylalanine level is 18 mg/dL. She asks about risks to her baby. Analysis of potential outcomes shows which combination of risks is most concerning if she continues current dietary habits through pregnancy?

Fetal microcephaly, intellectual disability, and congenital heart defects

Maternal thrombosis and fetal growth restriction only

Maternal seizures and gestational diabetes

Fetal PKU with severe early-onset symptoms

Maternal liver failure and fetal hydrops

Amino acid degradation pathways

START FOR FREE

Amino acid degradation pathways

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

START FOR FREE

Amino acid degradation pathways

Amino acid degradation pathways

On this page

Enjoying this lesson?